RxDoctor Payments Data

Margaret Gaynor, APRN

Nurse Practitioner · McHenry, ILNPI 1164890869

Payments from drug & device makers

$5,789in general payments, 2019–2025

Across 102 payments — averaging $56.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • AstraZeneca$591
  • GSK$285
  • Steris Corporation$247
  • Boehringer Ingelheim$191
  • Pfizer$149
  • plus $815 from 13 others

What the payments were for

  • Travel & lodging$2,37741%
  • Food & beverage$3,40359%
  • Gifts$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,789 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$34,123
Medicare patients
210
Services billed
332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$71,249
Breo ElliptaFluticasone/Vilanterol40$27,185
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$17,724
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr29$15,180
Incruse ElliptaUmeclidinium Bromide15$7,847
Arnuity ElliptaFluticasone Furoate14$5,541
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,514
Albuterol Sulfate HfaAlbuterol Sulfate70$2,170
Wixela InhubFluticasone Propion/Salmeterol11$2,124
Azithromycin37$192
Prednisone44$180
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$106

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta$285$127,003158 claims
AstraZenecaBreztri Aerosphere$591$17,72423 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in McHenry

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →